The NO-responsive liposome was designed to NIR-trigger drug release and inhibits P-gp in combination with Au-nanorod-embedded CuS shell, allowing NO and DOX release in drug-resistant tumor cells to kill MDR cancer cells (Wang et al., 2019a). Here, PGP is linked to neoplasm.